Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The REM Sleep Behavior Disorder Screening Questionnaire : A New Diagnostic Instrument

Identifieur interne : 001959 ( PascalFrancis/Curation ); précédent : 001958; suivant : 001960

The REM Sleep Behavior Disorder Screening Questionnaire : A New Diagnostic Instrument

Auteurs : Karin Stiasny-Kolster [Allemagne] ; Geert Mayer [Allemagne] ; Sylvia Sch Fer [Allemagne] ; Jens Carsten Möller [Allemagne] ; Monika Heinzel-Gutenbrunner [Allemagne] ; Wolfgang H. Oertel [Allemagne]

Source :

RBID : Pascal:08-0147411

Descripteurs français

English descriptors

Abstract

Many patients with assumed idiopathic REM sleep behavior disorder (RBD) may actually represent an early clinical manifestation of an evolving neurodegenerative disorder, such as the α-synucleinopathies, Parkinson's disease or multiple system atrophy. Early detection of these patients is clinically relevant for long-term prospective as well as future neuroprotective studies. For this purpose, we validated a 10-item patient self-rating questionnaire (maximum total score 13 points) covering the clinical features of RBD. The RBD screening questionnaire (RBDSQ) was applied to 54 patients with polysomnographically confirmed RBD (29 men; mean age 53.7 ± 15.8 years), 160 control subjects (81 men; mean age 50.8 ± 15.5 years) in whom RBD was excluded by history and polysomnography (PSG, control group 1) and 133 unselected healthy subjects (58 men; mean age 46.9 ± 12.3 years; no PSG, control group 2). In most subjects (n = 153) of control group 1, other sleep-wake disturbances were present. The mean RBDSQ score in the RBD group was 9.5 ± 2.8 points compared with 4.6 ± 3.0 points in control group 1 (P < 0.0001). Considering an RBDSQ score of five points as a positive test result, we found a sensitivity of 0.96 and a specificity of 0.56. The RBDSQ poorly discriminated patients with the most challenging differential diagnoses such as sleepwalking or epilepsy. In control group 2, the mean RBDSQ score (2.02 ± 1.78) was significantly lower than in the RBD group (P < 0.0005), revealing a specificity of 0.92. Due to its high sensitivity, the RBDSQ appears to be particularly useful as a screening tool.
pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 22
A06       @2 16
A08 01  1  ENG  @1 The REM Sleep Behavior Disorder Screening Questionnaire : A New Diagnostic Instrument
A11 01  1    @1 STIASNY-KOLSTER (Karin)
A11 02  1    @1 MAYER (Geert)
A11 03  1    @1 SCHÄFER (Sylvia)
A11 04  1    @1 MÖLLER (Jens Carsten)
A11 05  1    @1 HEINZEL-GUTENBRUNNER (Monika)
A11 06  1    @1 OERTEL (Wolfgang H.)
A14 01      @1 Department of Neurology, Center of Nervous Diseases, Philipps-University @2 Marburg @3 DEU @Z 1 aut. @Z 3 aut. @Z 4 aut. @Z 6 aut.
A14 02      @1 Department of Neurology, Hephata-Klinik @2 Schwalmstadt-Treysa @3 DEU @Z 2 aut.
A14 03      @1 Department of Child and Adolescent Psychiatry and Psychotherapy, Philipps-University @2 Marburg @3 DEU @Z 5 aut.
A20       @1 2386-2393
A21       @1 2007
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000162715700130
A44       @0 0000 @1 © 2008 INIST-CNRS. All rights reserved.
A45       @0 58 ref.
A47 01  1    @0 08-0147411
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 Many patients with assumed idiopathic REM sleep behavior disorder (RBD) may actually represent an early clinical manifestation of an evolving neurodegenerative disorder, such as the α-synucleinopathies, Parkinson's disease or multiple system atrophy. Early detection of these patients is clinically relevant for long-term prospective as well as future neuroprotective studies. For this purpose, we validated a 10-item patient self-rating questionnaire (maximum total score 13 points) covering the clinical features of RBD. The RBD screening questionnaire (RBDSQ) was applied to 54 patients with polysomnographically confirmed RBD (29 men; mean age 53.7 ± 15.8 years), 160 control subjects (81 men; mean age 50.8 ± 15.5 years) in whom RBD was excluded by history and polysomnography (PSG, control group 1) and 133 unselected healthy subjects (58 men; mean age 46.9 ± 12.3 years; no PSG, control group 2). In most subjects (n = 153) of control group 1, other sleep-wake disturbances were present. The mean RBDSQ score in the RBD group was 9.5 ± 2.8 points compared with 4.6 ± 3.0 points in control group 1 (P < 0.0001). Considering an RBDSQ score of five points as a positive test result, we found a sensitivity of 0.96 and a specificity of 0.56. The RBDSQ poorly discriminated patients with the most challenging differential diagnoses such as sleepwalking or epilepsy. In control group 2, the mean RBDSQ score (2.02 ± 1.78) was significantly lower than in the RBD group (P < 0.0005), revealing a specificity of 0.92. Due to its high sensitivity, the RBDSQ appears to be particularly useful as a screening tool.
C02 01  X    @0 002B17
C03 01  X  FRE  @0 Trouble du sommeil @5 01
C03 01  X  ENG  @0 Sleep disorder @5 01
C03 01  X  SPA  @0 Trastorno sueño @5 01
C03 02  X  FRE  @0 Maladie de Parkinson @2 NM @5 02
C03 02  X  ENG  @0 Parkinson disease @2 NM @5 02
C03 02  X  SPA  @0 Parkinson enfermedad @2 NM @5 02
C03 03  X  FRE  @0 Pathologie du système nerveux @5 03
C03 03  X  ENG  @0 Nervous system diseases @5 03
C03 03  X  SPA  @0 Sistema nervioso patología @5 03
C03 04  X  FRE  @0 Sommeil paradoxal @5 09
C03 04  X  ENG  @0 Rapid eye movement sleep @5 09
C03 04  X  SPA  @0 Sueño paradojal @5 09
C03 05  X  FRE  @0 Comportement @5 10
C03 05  X  ENG  @0 Behavior @5 10
C03 05  X  SPA  @0 Conducta @5 10
C03 06  X  FRE  @0 Dépistage @5 11
C03 06  X  ENG  @0 Medical screening @5 11
C03 06  X  SPA  @0 Descubrimiento @5 11
C03 07  X  FRE  @0 Questionnaire @5 12
C03 07  X  ENG  @0 Questionnaire @5 12
C03 07  X  SPA  @0 Cuestionario @5 12
C03 08  X  FRE  @0 Diagnostic @5 13
C03 08  X  ENG  @0 Diagnosis @5 13
C03 08  X  SPA  @0 Diagnóstico @5 13
C03 09  X  FRE  @0 Instrument @5 14
C03 09  X  ENG  @0 Instrument @5 14
C03 09  X  SPA  @0 Instrumento @5 14
C03 10  X  FRE  @0 Sensibilité @5 15
C03 10  X  ENG  @0 Sensitivity @5 15
C03 10  X  SPA  @0 Sensibilidad @5 15
C03 11  X  FRE  @0 Spécificité @5 16
C03 11  X  ENG  @0 Specificity @5 16
C03 11  X  SPA  @0 Especificidad @5 16
C07 01  X  FRE  @0 Cycle veille sommeil @5 37
C07 01  X  ENG  @0 Sleep wake cycle @5 37
C07 01  X  SPA  @0 Ciclo sueño vigilia @5 37
C07 02  X  FRE  @0 Trouble neurologique @5 39
C07 02  X  ENG  @0 Neurological disorder @5 39
C07 02  X  SPA  @0 Trastorno neurológico @5 39
C07 03  X  FRE  @0 Pathologie de l'encéphale @5 40
C07 03  X  ENG  @0 Cerebral disorder @5 40
C07 03  X  SPA  @0 Encéfalo patología @5 40
C07 04  X  FRE  @0 Syndrome extrapyramidal @5 41
C07 04  X  ENG  @0 Extrapyramidal syndrome @5 41
C07 04  X  SPA  @0 Extrapiramidal síndrome @5 41
C07 05  X  FRE  @0 Maladie dégénérative @5 42
C07 05  X  ENG  @0 Degenerative disease @5 42
C07 05  X  SPA  @0 Enfermedad degenerativa @5 42
C07 06  X  FRE  @0 Pathologie du système nerveux central @5 43
C07 06  X  ENG  @0 Central nervous system disease @5 43
C07 06  X  SPA  @0 Sistema nervosio central patología @5 43
N21       @1 091
N44 01      @1 OTO
N82       @1 OTO

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:08-0147411

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">The REM Sleep Behavior Disorder Screening Questionnaire : A New Diagnostic Instrument</title>
<author>
<name sortKey="Stiasny Kolster, Karin" sort="Stiasny Kolster, Karin" uniqKey="Stiasny Kolster K" first="Karin" last="Stiasny-Kolster">Karin Stiasny-Kolster</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Center of Nervous Diseases, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Mayer, Geert" sort="Mayer, Geert" uniqKey="Mayer G" first="Geert" last="Mayer">Geert Mayer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Neurology, Hephata-Klinik</s1>
<s2>Schwalmstadt-Treysa</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Sch Fer, Sylvia" sort="Sch Fer, Sylvia" uniqKey="Sch Fer S" first="Sylvia" last="Sch Fer">Sylvia Sch Fer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Center of Nervous Diseases, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Moller, Jens Carsten" sort="Moller, Jens Carsten" uniqKey="Moller J" first="Jens Carsten" last="Möller">Jens Carsten Möller</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Center of Nervous Diseases, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Heinzel Gutenbrunner, Monika" sort="Heinzel Gutenbrunner, Monika" uniqKey="Heinzel Gutenbrunner M" first="Monika" last="Heinzel-Gutenbrunner">Monika Heinzel-Gutenbrunner</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Department of Child and Adolescent Psychiatry and Psychotherapy, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Oertel, Wolfgang H" sort="Oertel, Wolfgang H" uniqKey="Oertel W" first="Wolfgang H." last="Oertel">Wolfgang H. Oertel</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Center of Nervous Diseases, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">08-0147411</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 08-0147411 INIST</idno>
<idno type="RBID">Pascal:08-0147411</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001360</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001959</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">The REM Sleep Behavior Disorder Screening Questionnaire : A New Diagnostic Instrument</title>
<author>
<name sortKey="Stiasny Kolster, Karin" sort="Stiasny Kolster, Karin" uniqKey="Stiasny Kolster K" first="Karin" last="Stiasny-Kolster">Karin Stiasny-Kolster</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Center of Nervous Diseases, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Mayer, Geert" sort="Mayer, Geert" uniqKey="Mayer G" first="Geert" last="Mayer">Geert Mayer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Neurology, Hephata-Klinik</s1>
<s2>Schwalmstadt-Treysa</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Sch Fer, Sylvia" sort="Sch Fer, Sylvia" uniqKey="Sch Fer S" first="Sylvia" last="Sch Fer">Sylvia Sch Fer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Center of Nervous Diseases, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Moller, Jens Carsten" sort="Moller, Jens Carsten" uniqKey="Moller J" first="Jens Carsten" last="Möller">Jens Carsten Möller</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Center of Nervous Diseases, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Heinzel Gutenbrunner, Monika" sort="Heinzel Gutenbrunner, Monika" uniqKey="Heinzel Gutenbrunner M" first="Monika" last="Heinzel-Gutenbrunner">Monika Heinzel-Gutenbrunner</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Department of Child and Adolescent Psychiatry and Psychotherapy, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Oertel, Wolfgang H" sort="Oertel, Wolfgang H" uniqKey="Oertel W" first="Wolfgang H." last="Oertel">Wolfgang H. Oertel</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Center of Nervous Diseases, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Behavior</term>
<term>Diagnosis</term>
<term>Instrument</term>
<term>Medical screening</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Questionnaire</term>
<term>Rapid eye movement sleep</term>
<term>Sensitivity</term>
<term>Sleep disorder</term>
<term>Specificity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Trouble du sommeil</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Sommeil paradoxal</term>
<term>Comportement</term>
<term>Dépistage</term>
<term>Questionnaire</term>
<term>Diagnostic</term>
<term>Instrument</term>
<term>Sensibilité</term>
<term>Spécificité</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Many patients with assumed idiopathic REM sleep behavior disorder (RBD) may actually represent an early clinical manifestation of an evolving neurodegenerative disorder, such as the α-synucleinopathies, Parkinson's disease or multiple system atrophy. Early detection of these patients is clinically relevant for long-term prospective as well as future neuroprotective studies. For this purpose, we validated a 10-item patient self-rating questionnaire (maximum total score 13 points) covering the clinical features of RBD. The RBD screening questionnaire (RBDSQ) was applied to 54 patients with polysomnographically confirmed RBD (29 men; mean age 53.7 ± 15.8 years), 160 control subjects (81 men; mean age 50.8 ± 15.5 years) in whom RBD was excluded by history and polysomnography (PSG, control group 1) and 133 unselected healthy subjects (58 men; mean age 46.9 ± 12.3 years; no PSG, control group 2). In most subjects (n = 153) of control group 1, other sleep-wake disturbances were present. The mean RBDSQ score in the RBD group was 9.5 ± 2.8 points compared with 4.6 ± 3.0 points in control group 1 (P < 0.0001). Considering an RBDSQ score of five points as a positive test result, we found a sensitivity of 0.96 and a specificity of 0.56. The RBDSQ poorly discriminated patients with the most challenging differential diagnoses such as sleepwalking or epilepsy. In control group 2, the mean RBDSQ score (2.02 ± 1.78) was significantly lower than in the RBD group (P < 0.0005), revealing a specificity of 0.92. Due to its high sensitivity, the RBDSQ appears to be particularly useful as a screening tool.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>22</s2>
</fA05>
<fA06>
<s2>16</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>The REM Sleep Behavior Disorder Screening Questionnaire : A New Diagnostic Instrument</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>STIASNY-KOLSTER (Karin)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>MAYER (Geert)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>SCHÄFER (Sylvia)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>MÖLLER (Jens Carsten)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>HEINZEL-GUTENBRUNNER (Monika)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>OERTEL (Wolfgang H.)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Neurology, Center of Nervous Diseases, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Neurology, Hephata-Klinik</s1>
<s2>Schwalmstadt-Treysa</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Department of Child and Adolescent Psychiatry and Psychotherapy, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20>
<s1>2386-2393</s1>
</fA20>
<fA21>
<s1>2007</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000162715700130</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2008 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>58 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>08-0147411</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Many patients with assumed idiopathic REM sleep behavior disorder (RBD) may actually represent an early clinical manifestation of an evolving neurodegenerative disorder, such as the α-synucleinopathies, Parkinson's disease or multiple system atrophy. Early detection of these patients is clinically relevant for long-term prospective as well as future neuroprotective studies. For this purpose, we validated a 10-item patient self-rating questionnaire (maximum total score 13 points) covering the clinical features of RBD. The RBD screening questionnaire (RBDSQ) was applied to 54 patients with polysomnographically confirmed RBD (29 men; mean age 53.7 ± 15.8 years), 160 control subjects (81 men; mean age 50.8 ± 15.5 years) in whom RBD was excluded by history and polysomnography (PSG, control group 1) and 133 unselected healthy subjects (58 men; mean age 46.9 ± 12.3 years; no PSG, control group 2). In most subjects (n = 153) of control group 1, other sleep-wake disturbances were present. The mean RBDSQ score in the RBD group was 9.5 ± 2.8 points compared with 4.6 ± 3.0 points in control group 1 (P < 0.0001). Considering an RBDSQ score of five points as a positive test result, we found a sensitivity of 0.96 and a specificity of 0.56. The RBDSQ poorly discriminated patients with the most challenging differential diagnoses such as sleepwalking or epilepsy. In control group 2, the mean RBDSQ score (2.02 ± 1.78) was significantly lower than in the RBD group (P < 0.0005), revealing a specificity of 0.92. Due to its high sensitivity, the RBDSQ appears to be particularly useful as a screening tool.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Trouble du sommeil</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Sleep disorder</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Trastorno sueño</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Pathologie du système nerveux</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Sommeil paradoxal</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Rapid eye movement sleep</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Sueño paradojal</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Comportement</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Behavior</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Conducta</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Dépistage</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Medical screening</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Descubrimiento</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Questionnaire</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Questionnaire</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Cuestionario</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Diagnostic</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Diagnosis</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Diagnóstico</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Instrument</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Instrument</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Instrumento</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Sensibilité</s0>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Sensitivity</s0>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Sensibilidad</s0>
<s5>15</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Spécificité</s0>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Specificity</s0>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Especificidad</s0>
<s5>16</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Cycle veille sommeil</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Sleep wake cycle</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Ciclo sueño vigilia</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>39</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Pathologie de l'encéphale</s0>
<s5>40</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>40</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Syndrome extrapyramidal</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Pathologie du système nerveux central</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>43</s5>
</fC07>
<fN21>
<s1>091</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001959 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001959 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:08-0147411
   |texte=   The REM Sleep Behavior Disorder Screening Questionnaire : A New Diagnostic Instrument
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024